This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Applied Therapeutics Securities Class Action
Regulatory class action

Applied Therapeutics Securities Class Action

Analysis based on 6 articles · First reported Jan 04, 2025 · Last updated Feb 14, 2025

Sentiment
-50
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the potential for a significant financial penalty for Applied Therapeutics, which could negatively affect its stock price. Investors who purchased Applied Therapeutics securities during the Class Period may suffer losses.

Biotechnology Legal Services
Event Summary

A securities class action lawsuit has been filed against Applied Therapeutics in the United States — United States District Court for the Northern District of California. The lawsuit, brought by Kessler Topaz Meltzer & Check, alleges that Applied Therapeutics made false and misleading statements to investors between January 3, 2024, and December 2, 2024. Specifically, the complaint claims that Applied Therapeutics failed to disclose its non-adherence to trial protocol and good clinical practices for its drug candidate, govorestat, which created a severe risk that the trial data would be rejected by the United States — Food and Drug Administration. Investors who suffered losses during this period are encouraged to seek lead plaintiff status by February 18, 2025.

Entities Involved
stock
Applied Therapeutics
Applied Therapeutics is the defendant in the securities class action lawsuit, accused of making false and misleading statements regarding its drug candidate govorestat.
Importance 100.0 Sentiment -70.0
priv
Kessler Topaz Meltzer & Check
Kessler Topaz Meltzer & Check is the law firm informing investors about the securities class action lawsuit against Applied Therapeutics, Inc. and is encouraging investors to join.
Importance 70.0 Sentiment 20.0
govactor
United States — Food and Drug Administration
The United States — Food and Drug Administration is the regulatory body that could reject the trial data for govorestat, which is a key allegation in the lawsuit against Applied Therapeutics.
Importance 50.0 Sentiment 0.0
govactor
United States — United States District Court for the Northern District of California
The United States — United States District Court for the Northern District of California is where the securities class action lawsuit against Applied Therapeutics is filed.
Importance 40.0 Sentiment 0.0
per
Jonathan Naji
Jonathan Naji is an attorney at Kessler Topaz Meltzer & Check, serving as a contact for investors interested in the lawsuit.
Importance 30.0 Sentiment 0.0
Relationships
Applied Therapeutics regulated ↔ United States — Food and Drug Administration Applied Therapeutics is a biopharmaceutical company strictly regulated by the FDA. The agency recently denied approval f
Kessler Topaz Meltzer & Check related ↔ United States — United States District Court for the Northern District of California
Kessler Topaz Meltzer & Check related ↔ Jonathan Naji
United States — Food and Drug Administration related ↔ United States — United States District Court for the Northern District of California
United States — United States District Court for the Northern District of California related ↔ Jonathan Naji
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.